Literature DB >> 28918484

Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern.

Haider Rahman1, Marina Kim2, Galen Leung3, Jesse A Green4, Seymour Katz5,6.   

Abstract

OPINION STATEMENT: Inflammatory bowel disease (IBD), which includes conditions such as Crohn's disease and ulcerative colitis, is becoming more prevalent with the elderly being the fastest growing group. Parallel to this, there is an increasing interest in the use of complementary and alternative medicine (CAM). Nearly half of patients with IBD have used CAM at one time. The elderly patients, however, are burdened by comorbid conditions, polypharmacy, and altered functional status. With increasing use of complementary and alternative medicine in our elderly patients with IBD, it is vital for the provider to provide counsel on drug-herb potential interactions. CAM includes herbal products, diet, dietary supplements, acupuncture, and prayer. In this paper, we will review common CAM, specifically herbs, that are used in patients with IBD including the herb background, suggested use, evidence in IBD, and most importantly, potential interactions with IBD medications used in elderly patients. Most important evidence-based adverse events and drug-herb interactions are summarized. The herbs discussed include Triticum aestivum (wheat grass), Andrographis paniculata (chiretta), Boswellia serrata, tormentil, bilberry, curcumin (turmeric), Plantago ovata (blond psyllium), Oenothera biennis (evening primrose oil), germinated barley foodstuff, an herbal preparation of myrrh, chamomile and coffee extract, chios mastic gum, wormwood (absinthe, thujone), Cannabis sativa (marijuana, THC), tripterygium wilfordii (thunder god vine), Ulmus rubra (slippery elm bark), trigonella foenugraecum (fenugreek), Dioscorea mexicana (wild yam), Harpagophytum procumbens (devil's claw), ginger, cinnamon, licorice, and peppermint.

Entities:  

Keywords:  Absinthe; Adverse events; Aging; Alternative; Barley; CAM; Cannabis; Chios mastic gum; Cinnamon; Complementary; Crohn’s disease; Drug-herb interactions; Elderly; Ginger; Herbal; IBD; Inflammatory bowel disease; Interactions; Licorice; Marijuana; Peppermint; Primrose; THC; Turmeric; Ulcerative colitis; Wheatgrass; Wormwood

Year:  2017        PMID: 28918484     DOI: 10.1007/s11938-017-0154-y

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  185 in total

1.  Germinated barley foodstuff feeding. A novel neutraceutical therapeutic strategy for ulcerative colitis.

Authors:  O Kanauchi; T Iwanaga; K Mitsuyama
Journal:  Digestion       Date:  2001       Impact factor: 3.216

2.  Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP.

Authors:  Hiroyuki Kusuhara; Hidetoshi Furuie; Akihiro Inano; Akihiro Sunagawa; Saiko Yamada; Chunyong Wu; Shinya Fukizawa; Nozomi Morimoto; Ichiro Ieiri; Mariko Morishita; Kiminobu Sumita; Hiroshi Mayahara; Takuya Fujita; Kazuya Maeda; Yuichi Sugiyama
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 3.  Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa).

Authors:  Nita Chainani-Wu
Journal:  J Altern Complement Med       Date:  2003-02       Impact factor: 2.579

4.  "Giant colonic bezoar:" a medication bezoar due to psyllium seed husks.

Authors:  F P Agha; T T Nostrant; R G Fiddian-Green
Journal:  Am J Gastroenterol       Date:  1984-04       Impact factor: 10.864

Review 5.  Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders.

Authors:  L G Darlington; T W Stone
Journal:  Br J Nutr       Date:  2001-03       Impact factor: 3.718

6.  The effects of cannabinoids and cannabispiro compounds on Escherichia coli adhesion to tissue culture cells and on leukocyte functions in vitro.

Authors:  J Molnár; I Petri; I Berek; Y Shoyama; I Nishioka
Journal:  Acta Microbiol Hung       Date:  1987

7.  Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production.

Authors:  X Tao; H Schulze-Koops; L Ma; J Cai; Y Mao; P E Lipsky
Journal:  Arthritis Rheum       Date:  1998-01

8.  Cinnamaldehyde inhibits lymphocyte proliferation and modulates T-cell differentiation.

Authors:  W S Koh; S Y Yoon; B M Kwon; T C Jeong; K S Nam; M Y Han
Journal:  Int J Immunopharmacol       Date:  1998-11

9.  Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine.

Authors:  Jianan Ren; Xiuwen Wu; Nansheng Liao; Gefei Wang; Chaogang Fan; Song Liu; Huajian Ren; Yunzhao Zhao; Jieshou Li
Journal:  J Int Med Res       Date:  2013-01-24       Impact factor: 1.671

10.  [Analysis of minor curcuminoids in Curcuma longa L. by high performance liquid chromatography-tandem mass spectrometry].

Authors:  Wei Li; Hongbin Xiao; Longxing Wang; Xinmiao Liang
Journal:  Se Pu       Date:  2009-05
View more
  4 in total

1.  Polypharmacy in Multiple Sclerosis: Current Knowledge and Future Directions.

Authors:  Joanie Thelen; Valeriy Zvonarev; Sarah Lam; Crystal Burkhardt; Sharon Lynch; Jared Bruce
Journal:  Mo Med       Date:  2021 May-Jun

2.  Quantitative Determination of Andrographolide and Related Compounds in Andrographis paniculata Extracts and Biological Evaluation of Their Anti-Inflammatory Activity.

Authors:  Emmanuelle Villedieu-Percheron; Véronique Ferreira; Joana Filomena Campos; Emilie Destandau; Chantal Pichon; Sabine Berteina-Raboin
Journal:  Foods       Date:  2019-12-14

Review 3.  Clinical Implications of Herbal Supplements in Conventional Medical Practice: A US Perspective.

Authors:  Gashaw Hassen; Gizeshwork Belete; Keila G Carrera; Rosemary O Iriowen; Haimanot Araya; Tadesse Alemu; Nebiyou Solomon; Diwas S Bam; Sophia M Nicola; Michael E Araya; Tadesse Debele; Michlene Zouetr; Nidhi Jain
Journal:  Cureus       Date:  2022-07-15

Review 4.  Herb-Drug Interaction in Inflammatory Diseases: Review of Phytomedicine and Herbal Supplements.

Authors:  Annemarie Lippert; Bertold Renner
Journal:  J Clin Med       Date:  2022-03-12       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.